Hostile bidders are more courageous than they would have been a few years ago.

You get to see your stuff made. It's just like, 'Wow, I wrote this a week ago and now I'm seeing it.' It's unbelievable what you can do in three days in TV.

Even though management is saying the cancer trial was not a focus for them, it is never a good thing to have a failed trial.

Defense mechanisms in this country are seen by regulators as a means to improve shareholder value, not to thwart bids.

What we're witnessing now is possibly the most robust period of M&A that we have seen in the past 10 years.

If you have this many bidders, the seller has a picnic. He'll play one off the other.